ACRIX | CRDRX | ACRIX / CRDRX | |
Total Expense Ratio | 1.18 | 0.82 | 144% |
Annual Report Gross Expense Ratio | 1.18 | 0.82 | 144% |
Fund Existence | 9 years | 13 years | - |
Gain YTD | 11.535 | 12.644 | 91% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 10000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.4B | 2.5B | 56% |
Annual Yield % from dividends | 0.49 | 2.24 | 22% |
Returns for 1 year | -0.94 | 10.29 | -9% |
Returns for 3 years | 36.23 | 34.65 | 105% |
Returns for 5 years | 33.87 | 11.60 | 292% |
Returns for 10 years | N/A | 36.61 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
DTCCX | 15.95 | 0.08 | +0.50% |
BNY Mellon Sust US Equity C | |||
FGRCX | 28.84 | 0.13 | +0.45% |
Fidelity Advisor Mega Cap Stock C | |||
ETIHX | 43.18 | 0.06 | +0.14% |
Eventide Healthcare & Life Sciences I | |||
ASQAX | 16.67 | -0.04 | -0.24% |
American Century Small Company A | |||
WICGX | 6.51 | -0.17 | -2.54% |
William Blair China Growth I |